🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-label, single-arm, multi-center, Phase IIa study to evaluate the effic...
Status
Unknown
Location
Research Site
Start Date
2016-12-22
Trial ID
NCT03190824
Treatments Being Tested
We try to assess the potential role of telomerase reverse transcriptase and...
Status
Completed
Location
Urology and Nephrology Center
Start Date
2018-08-01
Trial ID
NCT03591367
Treatments Being Tested
GX301 is an experimental therapeutic vaccine directed against human telomer...
Status
Completed
Location
S.C. di Oncologia, A.S.O. "Santi Antonio e Biagio e Cesare Arrigo"
Start Date
2014-11
Trial ID
NCT02293707
Treatments Being Tested
The purpose of this research is to develop a new and powerful type of immun...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT01153113
Treatments Being Tested
70% all cases of cervical cancer, 95% of anal cancers and about 70% of orop...
Status
Completed
Location
CHU de Besançon
Start Date
2020-02-18
Trial ID
NCT03946358
Treatments Being Tested
Patients with stage IV or recurrent stage I-III NSCLC with documented disea...
Status
Completed
Location
Fakultni nemocnice Plzen
Start Date
2012-08
Trial ID
NCT01935154
This is a phase II study to evaluate the safety, feasibility and efficacy o...
Status
Completed
Location
Emory University School of Medicine
Start Date
2007-07
Trial ID
NCT00510133
Treatments Being Tested
This is a Phase I/IIA, open-label, multi-center trial to evaluate the safet...
Status
Completed
Location
Mayo Clinic Cancer Center
Start Date
2018-05-24
Trial ID
NCT03502785
Treatments Being Tested
Phase 2 study to assess the efficacy of INVAC-1, a DNA plasmid encoding a m...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-07-25
Trial ID
NCT03265717
Treatments Being Tested
Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2018-05-31
Trial ID
NCT03491683
Treatments Being Tested